← Leaderboards
Roger F Soll
University Of Vermont &St Agric College
$32,903
Attributed
$32,903
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$32,903 · 2
By mechanism
M01$32,903 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Vermont &St Agric College
Same institution · by research overlap
- Charles G Irvin$19,268,591
- Matthew E Poynter$10,608,925
- Mercedes R. Rincon$17,614,161
- Anne E Dixon$9,543,525
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchDermatitisDexamethasoneDosage FormsHormone TherapyHuman Therapy EvaluationLow Birth Weight Infant HumanLung DisorderNewborn Human (0-6 Weeks)Nosocomial Infection ControlRespiratory Disorder ChemotherapySkinSkin InfectionChemopreventionSkin PharmacologyChronic Disease /Disorder
Grant awards (6)
EARLY POSTNATAL DEXAMETHASONE THERAPY FOR PREVENTION OF CHRONIC LUNG DISEASE$0
M01 · FY2002 · RR
EFFECT OF AQUAPHOR OINTMENT ON NOSOCOMIAL SEPSIS IN LOW BIRTH WEIGHT INFANTS$0
M01 · FY2002 · RR
EFFECT OF AQUAPHOR OINTMENT ON NOSOCOMIAL SEPSIS IN LOW BIRTH WEIGHT INFANTS$32,903
M01 · FY2000 · RR
EARLY POSTNATAL DEXAMETHASONE THERAPY FOR PREVENTION OF CHRONIC LUNG DISEASE$0
M01 · FY2000 · RR
EARLY POSTNATAL DEXAMETHASONE THERAPY FOR PREVENTION OF CHRONIC LUNG DISEASE$0
M01 · FY2000 · RR
EFFECT OF AQUAPHOR OINTMENT ON NOSOCOMIAL SEPSIS IN LOW BIRTH WEIGHT INFANTS$0
M01 · FY2000 · RR